Bally's (BALY) Financials

$10.53 +0.93 (+9.69%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$10.96 +0.43 (+4.07%)

As of 05/23/2025 08:00 PM Eastern

Annual Income Statements for Bally's

This table shows Bally's' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-568	-188	-426
Consolidated Net Income / (Loss)	-568	-188	-426
Net Income / (Loss) Continuing Operations	-568	-188	-426
Total Pre-Tax Income	-553	-186	-454
Total Operating Income	-258	104	-293
Total Gross Profit	1,327	1,344	1,246
Total Revenue	2,450	2,449	2,256
Operating Revenue	2,450	2,449	2,256
Total Cost of Revenue	1,123	1,105	1,009
Operating Cost of Revenue	1,123	1,105	1,009
Total Operating Expenses	1,586	1,240	1,539
Selling, General & Admin Expense	1,043	1,114	826
Depreciation Expense	380	350	301
Other Operating Expenses / (Income)	-86	-374	-51
Impairment Charge	249	150	464
Total Other Income / (Expense), net	-294	-290	-161
Interest & Investment Income	-290	-278	-208
Other Income / (Expense), net	-4.55	-12	47
Income Tax Expense	15	1.76	-29
Basic Earnings per Share	($11.71)	($3.51)	($7.32)
Weighted Average Basic Shares Outstanding	48.47M	53.35M	58.11M
Diluted Earnings per Share	($11.71)	($3.51)	($7.32)
Weighted Average Diluted Shares Outstanding	48.47M	53.35M	58.11M
Weighted Average Basic & Diluted Shares Outstanding	48.51M	40.09M	46.68M

This table shows Bally's' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-86	-248	-60	-174	-278	-62	-26	178	-488	0.59
Consolidated Net Income / (Loss)	-86	-248	-60	-174	-278	-62	-26	178	-488	0.59
Net Income / (Loss) Continuing Operations	-86	-248	-60	-174	-278	-62	-26	178	-488	0.59
Total Pre-Tax Income	-67	-281	-62	-143	-430	-18	-54	316	-517	1.73
Total Operating Income	-32	-158	5.57	-74	-316	37	5.98	377	-455	54
Total Gross Profit	313	344	337	334	335	345	335	329	328	328
Total Revenue	580	630	622	618	612	632	606	599	577	578
Operating Revenue	580	630	622	618	612	632	606	599	577	578
Total Cost of Revenue	268	286	285	284	277	287	271	270	248	251
Operating Cost of Revenue	268	286	285	284	277	287	271	270	248	251
Total Operating Expenses	345	501	331	408	651	308	329	-48	783	274
Selling, General & Admin Expense	269	274	252	248	382	231	250	252	246	200
Depreciation Expense	63	78	79	160	119	77	79	75	73	74
Other Operating Expenses / (Income)	-236	150	0.00	0.00	-	0.00	-0.14	-374	-	0.00
Total Other Income / (Expense), net	-34	-124	-67	-69	-114	-55	-60	-61	-63	-52
Other Income / (Expense), net	34	-50	6.93	4.55	-37	16	6.81	2.61	0.13	1.64
Income Tax Expense	19	-34	-1.50	31	-151	44	-29	138	-30	1.14
Basic Earnings per Share	($1.76)	($5.10)	($1.24)	($3.61)	($5.16)	($1.15)	($0.48)	$3.28	($8.34)	$0.01
Weighted Average Basic Shares Outstanding	48.47M	48.60M	48.50M	48.12M	53.35M	53.58M	53.94M	54.42M	58.11M	57.02M
Diluted Earnings per Share	($1.76)	($5.10)	($1.24)	($3.61)	($5.12)	($1.15)	($0.48)	$3.24	($8.34)	$0.01
Weighted Average Diluted Shares Outstanding	48.47M	48.60M	48.50M	48.12M	53.35M	53.58M	53.94M	55.09M	58.11M	57.06M
Weighted Average Basic & Diluted Shares Outstanding	48.51M	40.67M	40.63M	40.48M	40.09M	45.62M	45.63M	-	46.68M	47.26M

This table details how cash moves in and out of Bally's' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-84	50	-9.66
Net Cash From Operating Activities	114	189	271
Net Cash From Continuing Operating Activities	114	189	271
Net Income / (Loss) Continuing Operations	-568	-188	-426
Consolidated Net Income / (Loss)	-568	-188	-426
Depreciation Expense	380	350	301
Amortization Expense	12	11	11
Non-Cash Adjustments To Reconcile Net Income	268	13	437
Changes in Operating Assets and Liabilities, net	23	1.37	-52
Net Cash From Investing Activities	98	-208	-303
Net Cash From Continuing Investing Activities	98	-208	-303
Purchase of Property, Plant & Equipment	-246	-357	-450
Acquisitions	-3.30	-239	-201
Purchase of Investments	0.00	0.00	-3.18
Divestitures	-4.18	0.00	0.00
Sale and/or Maturity of Investments	4.06	0.00	0.00
Other Investing Activities, net	347	388	352
Net Cash From Financing Activities	-288	66	43
Net Cash From Continuing Financing Activities	-288	66	43
Repayment of Debt	-798	-283	-570
Repurchase of Common Equity	0.00	-99	-153
Issuance of Debt	440	448	597
Other Financing Activities, net	71	0.00	170
Effect of Exchange Rate Changes	-8.00	5.15	-21
Cash Interest Paid	314	250	201
Cash Income Taxes Paid	2.23	14	-38

This table details how cash moves in and out of Bally's' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-49	-44	13	-4.37	17	-75	-24	132	45	-11
Net Cash From Operating Activities	38	36	48	-7.85	70	54	80	-16	46	61
Net Cash From Continuing Operating Activities	38	36	48	-7.85	72	53	80	-16	46	61
Net Income / (Loss) Continuing Operations	-86	-248	-60	-174	-278	-62	-26	178	-488	0.59
Consolidated Net Income / (Loss)	-86	-248	-60	-174	-278	-62	-26	178	-488	0.59
Depreciation Expense	63	78	79	160	119	77	79	75	73	74
Amortization Expense	2.98	2.95	2.90	2.88	2.83	2.92	2.80	2.77	2.77	3.00
Non-Cash Adjustments To Reconcile Net Income	25	200	32	10	328	11	31	-356	451	13
Changes in Operating Assets and Liabilities, net	33	3.26	-6.40	-7.01	-100	23	-6.79	85	6.62	-29
Net Cash From Investing Activities	289	-103	-44	-43	-206	-226	-96	320	-233	-14
Net Cash From Continuing Investing Activities	289	-103	-44	-43	-206	-226	-96	320	-233	-14
Purchase of Property, Plant & Equipment	-54	-104	-46	-42	-55	-168	-83	-51	-235	-66
Acquisitions	-1.85	-0.45	-	-1.00	-136	-55	-8.25	-40	-1.92	-148
Sale and/or Maturity of Investments	0.78	1.22	-	-	-	-	-	-	-	-
Other Investing Activities, net	348	-0.34	0.08	-0.76	-15	-2.77	-4.34	411	3.52	200
Net Cash From Financing Activities	-364	16	8.48	51	145	95	-0.95	-174	233	-49
Net Cash From Continuing Financing Activities	-364	16	8.48	51	145	95	-0.95	-174	233	-49
Repayment of Debt	-482	-85	-105	-126	-36	-68	-25	-154	-208	-155
Issuance of Debt	130	80	95	135	250	163	35	0.00	262	225
Other Financing Activities, net	-11	21	19	42	-	-	-	0.00	200	-
Effect of Exchange Rate Changes	-12	7.28	1.63	-4.45	7.40	1.94	-7.01	2.82	-0.10	-9.22
Cash Interest Paid	58	98	58	100	53	63	52	83	37	70
Cash Income Taxes Paid	-7.11	23	-3.22	-10	-1.40	6.12	3.61	6.11	1.30	17

This table presents Bally's' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	5,860	6,861	6,300
Total Current Assets	448	572	523
Cash & Equivalents	171	163	213
Restricted Cash	60	152	53
Accounts Receivable	55	70	72
Inventories, net	19	15	14
Prepaid Expenses	115	108	101
Current Deferred & Refundable Income Taxes	26	62	54
Other Current Nonoperating Assets	0.00	1.82	17
Plant, Property, & Equipment, net	631	1,175	1,202
Total Noncurrent Assets	4,782	5,114	4,575
Goodwill	1,800	1,936	1,746
Intangible Assets	1,307	1,871	1,962
Noncurrent Deferred & Refundable Income Taxes	2.31	36	26
Other Noncurrent Operating Assets	1,672	1,271	842
Total Liabilities & Shareholders' Equity	5,860	6,861	6,300
Total Liabilities	5,829	6,225	5,494
Total Current Liabilities	678	875	756
Short-Term Debt	19	19	19
Accounts Payable	86	69	70
Accrued Expenses	481	652	574
Current Deferred & Payable Income Tax Liabilities	25	78	56
Other Current Liabilities	66	55	33
Other Current Nonoperating Liabilities	0.00	1.31	3.41
Total Noncurrent Liabilities	5,151	5,350	4,738
Long-Term Debt	3,299	3,643	3,469
Noncurrent Deferred & Payable Income Tax Liabilities	118	126	138
Other Noncurrent Operating Liabilities	1,734	1,582	1,131
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	31	636	806
Total Preferred & Common Equity	31	635	806
Preferred Stock	0.00	0.00	0.00
Total Common Equity	31	635	806
Common Stock	1,415	1,401	1,637
Retained Earnings	-1,124	-556	-535
Accumulated Other Comprehensive Income / (Loss)	-260	-210	-296
Other Equity Adjustments	0.00	0.00	0.00
Noncontrolling Interest	0.00	0.43	0.43

This table presents Bally's' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	9/30/2022
Total Assets	6,406	6,590	6,636	6,929	6,781	6,293
Total Current Assets	489	556	536	551	528	449
Cash & Equivalents	191	155	169	179	184	164
Restricted Cash	90	170	142	119	139	56
Accounts Receivable	61	66	67	73	66	64
Inventories, net	18	18	16	15	15	16
Prepaid Expenses	107	118	110	142	103	101
Current Deferred & Refundable Income Taxes	22	29	32	16	15	48
Other Current Nonoperating Assets	0.00	0.00	0.00	5.59	5.59	-
Plant, Property, & Equipment, net	795	1,125	1,101	1,192	1,156	971
Total Noncurrent Assets	5,121	4,910	4,999	5,187	5,098	4,874
Goodwill	1,994	1,910	1,915	1,866	1,820	1,857
Intangible Assets	1,760	1,760	1,813	2,010	1,938	2,176
Noncurrent Deferred & Refundable Income Taxes	6.87	2.85	13	29	24	16
Other Noncurrent Operating Assets	1,361	1,236	1,258	1,282	1,316	826
Total Liabilities & Shareholders' Equity	6,406	6,590	6,636	6,929	6,781	6,293
Total Liabilities	6,172	6,197	6,186	6,032	5,742	5,200
Total Current Liabilities	877	923	876	843	679	691
Short-Term Debt	19	19	19	19	29	19
Accounts Payable	73	94	59	212	78	43
Accrued Expenses	712	718	703	482	468	553
Current Deferred & Payable Income Tax Liabilities	13	35	41	79	54	35
Other Current Liabilities	60	56	53	49	48	41
Other Current Nonoperating Liabilities	0.00	0.00	0.00	1.40	1.56	-
Total Noncurrent Liabilities	5,295	5,273	5,310	5,190	5,063	4,509
Long-Term Debt	3,651	3,654	3,661	3,425	3,318	3,409
Noncurrent Deferred & Payable Income Tax Liabilities	92	147	151	217	201	165
Other Noncurrent Operating Liabilities	1,552	1,472	1,499	1,547	1,544	931
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	234	394	450	897	1,039	1,093
Total Preferred & Common Equity	233	393	449	897	1,039	1,092
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	233	393	449	897	1,039	1,092
Common Stock	1,412	1,408	1,403	1,601	1,595	1,661
Retained Earnings	-1,038	-790	-730	-413	-352	-58
Treasury Stock	0.00	0.00	0.00	0.00	0.00	0.00
Accumulated Other Comprehensive Income / (Loss)	-140	-224	-224	-291	-205	-510
Noncontrolling Interest	0.43	0.43	0.43	0.43	0.43	0.57

This table displays calculated financial ratios and metrics derived from Bally's' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	0.06%	8.57%	70.57%
EBITDA Growth	-71.69%	596.27%	-56.92%
EBIT Growth	-386.28%	137.28%	-21,318.78%
NOPAT Growth	-348.37%	135.50%	-413.77%
Net Income Growth	-202.80%	55.94%	-271.02%
EPS Growth	-233.62%	52.05%	-216.88%
Operating Cash Flow Growth	-39.56%	-30.39%	227.44%
Free Cash Flow Firm Growth	545.16%	-81.29%	116.55%
Invested Capital Growth	-21.70%	-0.83%	-16.11%
Revenue Q/Q Growth	-1.26%	1.45%	-0.94%
EBITDA Q/Q Growth	175.33%	48.19%	-91.32%
EBIT Q/Q Growth	57.43%	1,068.49%	-156.67%
NOPAT Q/Q Growth	52.34%	400.96%	-187.04%
Net Income Q/Q Growth	25.33%	52.73%	-445.58%
EPS Q/Q Growth	22.30%	47.85%	-469.70%
Operating Cash Flow Q/Q Growth	-22.15%	15.00%	14.22%
Free Cash Flow Firm Q/Q Growth	1,779.65%	-55.37%	125.79%
Invested Capital Q/Q Growth	-13.96%	-1.42%	-6.64%
Profitability Metrics	-	-	-
Gross Margin	54.17%	54.87%	55.26%
EBITDA Margin	5.24%	18.52%	2.89%
Operating Margin	-10.54%	4.25%	-12.99%
EBIT Margin	-10.73%	3.75%	-10.92%
Profit (Net Income) Margin	-23.17%	-7.66%	-18.87%
Tax Burden Percent	102.76%	100.95%	93.64%
Interest Burden Percent	210.18%	-202.28%	184.51%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-5.09%	1.82%	-4.66%
ROIC Less NNEP Spread (ROIC-NNEP)	-17.12%	-6.12%	-11.57%
Return on Net Nonoperating Assets (RNNOA)	-165.21%	-27.82%	-30.48%
Return on Equity (ROE)	-170.30%	-26.00%	-35.14%
Cash Return on Invested Capital (CROIC)	19.25%	2.65%	12.86%
Operating Return on Assets (OROA)	-4.13%	1.40%	-3.83%
Return on Assets (ROA)	-8.93%	-2.85%	-6.62%
Return on Common Equity (ROCE)	-170.19%	-25.99%	-35.08%
Return on Equity Simple (ROE_SIMPLE)	-1,837.27%	-29.51%	-52.81%
Net Operating Profit after Tax (NOPAT)	-181	73	-205
NOPAT Margin	-7.38%	2.97%	-9.09%
Net Nonoperating Expense Percent (NNEP)	12.03%	7.94%	6.91%
Return On Investment Capital (ROIC_SIMPLE)	-5.40%	1.69%	-4.78%
Cost of Revenue to Revenue	45.83%	45.13%	44.74%
SG&A Expenses to Revenue	42.58%	45.49%	36.61%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	64.71%	50.63%	68.25%
Earnings before Interest and Taxes (EBIT)	-263	92	-246
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	128	454	65
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	24.31	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.31	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.23	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.57	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	29.90	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	33.67	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	5.62	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	107.40	5.76	4.33
Long-Term Debt to Equity	106.77	5.73	4.30
Financial Leverage	9.65	4.55	2.63
Leverage Ratio	19.08	9.13	5.31
Compound Leverage Factor	40.10	-18.46	9.79
Debt to Total Capital	99.08%	85.21%	81.23%
Short-Term Debt to Total Capital	0.58%	0.45%	0.45%
Long-Term Debt to Total Capital	98.50%	84.76%	80.77%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.01%	0.01%
Common Equity to Total Capital	0.92%	14.78%	18.76%
Debt to EBITDA	25.85	8.08	53.56
Net Debt to EBITDA	24.05	7.38	49.48
Long-Term Debt to EBITDA	25.70	8.03	53.26
Debt to NOPAT	-18.35	50.31	-17.01
Net Debt to NOPAT	-17.07	45.98	-15.72
Long-Term Debt to NOPAT	-18.25	50.04	-16.91
Altman Z-Score	0.03	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.06%	0.06%	0.17%
Liquidity Ratios	-	-	-
Current Ratio	0.66	0.65	0.69
Quick Ratio	0.33	0.27	0.38
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	683	106	566
Operating Cash Flow to CapEx	46.41%	52.88%	60.21%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.39	0.37	0.35
Accounts Receivable Turnover	38.95	34.49	37.64
Inventory Turnover	66.17	76.70	78.60
Fixed Asset Turnover	2.71	2.06	2.21
Accounts Payable Turnover	14.50	15.88	12.81
Days Sales Outstanding (DSO)	9.37	10.58	9.70
Days Inventory Outstanding (DIO)	5.52	4.76	4.64
Days Payable Outstanding (DPO)	25.17	22.99	28.50
Cash Conversion Cycle (CCC)	-10.29	-7.65	-14.16
Capital & Investment Metrics	-	-	-
Invested Capital	3,118	3,983	4,016
Invested Capital Turnover	0.69	0.61	0.51
Increase / (Decrease) in Invested Capital	-864	-33	-771
Enterprise Value (EV)	3,839	0.00	0.00
Market Capitalization	751	0.00	0.00
Book Value per Share	$0.76	$13.93	$17.05
Tangible Book Value per Share	($75.65)	($69.52)	($61.41)
Total Capital	3,350	4,298	4,295
Total Debt	3,319	3,663	3,489
Total Long-Term Debt	3,299	3,643	3,469
Net Debt	3,088	3,347	3,223
Capital Expenditures (CapEx)	246	357	450
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-442	-598	-479
Debt-free Net Working Capital (DFNWC)	-210	-283	-214
Net Working Capital (NWC)	-230	-302	-233
Net Nonoperating Expense (NNE)	387	260	220
Net Nonoperating Obligations (NNO)	3,088	3,347	3,210
Total Depreciation and Amortization (D&A)	391	362	311
Debt-free, Cash-free Net Working Capital to Revenue	-18.03%	-24.43%	-21.23%
Debt-free Net Working Capital to Revenue	-8.59%	-11.55%	-9.47%
Net Working Capital to Revenue	-9.38%	-12.35%	-10.33%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($11.71)	($3.51)	($7.32)
Adjusted Weighted Average Basic Shares Outstanding	48.47M	53.35M	58.11M
Adjusted Diluted Earnings per Share	($11.71)	($3.51)	($7.32)
Adjusted Weighted Average Diluted Shares Outstanding	48.47M	53.35M	58.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.51M	40.09M	46.68M
Normalized Net Operating Profit after Tax (NOPAT)	-6.61	178	120
Normalized NOPAT Margin	-0.27%	7.26%	5.31%
Pre Tax Income Margin	-22.55%	-7.58%	-20.15%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-52.84%	-36.04%

This table displays calculated financial ratios and metrics derived from Bally's' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.12%	-0.40%	2.55%	3.30%	6.07%	9.38%	9.72%	9.20%	5.30%	83.70%
EBITDA Growth	129.31%	-195.19%	-0.62%	-79.59%	38.96%	0.77%	-49.65%	270.38%	-1,127.44%	617.21%
EBIT Growth	100.43%	-493.28%	-2.27%	-118.30%	22.30%	-4.59%	-88.45%	803.22%	-310.12%	548.88%
NOPAT Growth	89.78%	-523.39%	-6.84%	-124.36%	30.49%	41.71%	-94.64%	1,248.38%	-924.64%	-5.25%
Net Income Growth	69.18%	-301.05%	-134.67%	-197.52%	42.90%	-10,521.92%	-143.11%	9,340.76%	-322.88%	101.03%
EPS Growth	65.63%	-343.48%	-158.33%	-211.42%	38.61%	-11,600.00%	-148.98%	10,700.00%	-270.67%	100.86%
Operating Cash Flow Growth	-46.17%	-32.83%	-40.68%	51.25%	53.88%	-10.63%	-44.23%	-177.42%	283.30%	65.96%
Free Cash Flow Firm Growth	547.64%	6.18%	-34.13%	-193.10%	-141.49%	111.92%	118.48%	266.59%	112.88%	-177.78%
Invested Capital Growth	-21.70%	-10.29%	-7.81%	0.00%	-0.83%	-6.08%	-10.64%	0.00%	-16.11%	129.95%
Revenue Q/Q Growth	-7.87%	1.34%	0.51%	1.11%	-3.29%	4.33%	1.25%	13.77%	-0.27%	4.66%
EBITDA Q/Q Growth	153.43%	-234.58%	1.04%	140.34%	-273.52%	40.51%	-79.25%	163.79%	-386.45%	-29.80%
EBIT Q/Q Growth	100.74%	-1,759.67%	118.02%	80.34%	-769.16%	312.44%	-96.63%	147.91%	-921.63%	-50.07%
NOPAT Q/Q Growth	79.52%	-2,928.91%	107.54%	76.59%	-948.48%	522.47%	-98.03%	137.55%	-1,829.68%	-76.47%
Net Income Q/Q Growth	65.39%	-311.75%	65.39%	37.53%	-350.44%	-140.93%	-114.38%	126.86%	-82,314.00%	-99.00%
EPS Q/Q Growth	65.49%	-311.29%	65.65%	29.49%	-345.22%	-139.58%	-114.81%	128.05%	-83,500.00%	-98.98%
Operating Cash Flow Q/Q Growth	3.68%	-23.29%	705.46%	-111.18%	29.36%	-32.25%	597.53%	-135.29%	-24.87%	-57.72%
Free Cash Flow Firm Q/Q Growth	175.62%	-4.87%	108.29%	-1,958.77%	-165.38%	-40.99%	-88.28%	1,925.88%	118.78%	8.50%
Invested Capital Q/Q Growth	-13.96%	-3.16%	-2.01%	-4.10%	-1.42%	-0.48%	0.00%	-100.00%	-6.64%	-5.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.86%	54.56%	54.17%	54.04%	54.75%	54.60%	55.26%	54.90%	56.95%	56.65%
EBITDA Margin	11.67%	-20.12%	15.15%	15.07%	-37.78%	21.06%	15.63%	76.27%	-65.64%	22.85%
Operating Margin	-5.56%	-25.03%	0.90%	-11.96%	-51.65%	5.89%	0.99%	62.92%	-78.81%	9.28%
EBIT Margin	0.26%	-32.94%	2.01%	-11.22%	-57.72%	8.34%	2.11%	63.36%	-78.79%	9.56%
Profit (Net Income) Margin	-14.78%	-39.34%	-9.68%	-28.12%	-45.51%	-9.77%	-4.23%	29.79%	-84.54%	0.10%
Tax Burden Percent	128.45%	88.05%	97.57%	122.02%	64.79%	345.92%	47.24%	56.42%	94.22%	34.28%
Interest Burden Percent	-4,353.91%	135.65%	-493.46%	205.37%	121.69%	-33.86%	-424.45%	83.32%	113.88%	3.13%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	43.58%	0.00%	65.72%
Return on Invested Capital (ROIC)	-2.69%	-11.35%	0.40%	-10.82%	-22.14%	2.39%	0.37%	0.00%	-28.27%	2.35%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.65%	-15.55%	-1.61%	-18.07%	-23.89%	-0.38%	-0.60%	0.00%	-33.58%	1.40%
Return on Net Nonoperating Assets (RNNOA)	-44.89%	-89.86%	-7.17%	-135.37%	-108.60%	-1.22%	-1.50%	0.00%	-88.47%	2.19%
Return on Equity (ROE)	-47.58%	-101.20%	-6.77%	-146.19%	-130.74%	1.17%	-1.13%	0.00%	-116.75%	4.53%
Cash Return on Invested Capital (CROIC)	19.25%	0.95%	1.90%	-212.71%	2.65%	5.69%	5.17%	0.00%	12.86%	-71.14%
Operating Return on Assets (OROA)	0.10%	-12.26%	0.75%	-4.17%	-21.48%	3.05%	0.75%	0.00%	-27.66%	3.87%
Return on Assets (ROA)	-5.69%	-14.64%	-3.60%	-10.46%	-16.94%	-3.57%	-1.50%	0.00%	-29.67%	0.04%
Return on Common Equity (ROCE)	-47.55%	-101.13%	-6.77%	-146.05%	-130.67%	1.17%	-1.13%	0.00%	-116.55%	4.53%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-325.75%	-146.09%	-120.11%	0.00%	-44.24%	-49.17%	0.00%	0.00%	11.27%
Net Operating Profit after Tax (NOPAT)	-23	-110	3.90	-52	-221	26	4.19	213	-318	18
NOPAT Margin	-3.89%	-17.52%	0.63%	-8.37%	-36.16%	4.12%	0.69%	35.50%	-55.17%	3.18%
Net Nonoperating Expense Percent (NNEP)	1.96%	4.21%	2.01%	7.25%	1.75%	2.77%	0.97%	0.00%	5.31%	0.95%
Return On Investment Capital (ROIC_SIMPLE)	-0.67%	-	-	-	-5.15%	-	-	-	-7.41%	-
Cost of Revenue to Revenue	46.14%	45.44%	45.83%	45.96%	45.25%	45.40%	44.74%	45.10%	43.05%	43.35%
SG&A Expenses to Revenue	46.36%	43.43%	40.60%	40.17%	62.42%	36.46%	41.23%	42.02%	42.64%	34.59%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	59.42%	79.59%	53.28%	66.00%	106.40%	48.71%	54.27%	-8.02%	135.76%	47.37%
Earnings before Interest and Taxes (EBIT)	1.53	-208	13	-69	-353	53	13	379	-454	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	68	-127	94	93	-231	133	95	457	-379	132
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	24.31	3.00	1.23	1.24	0.00	0.67	0.69	0.00	0.00	0.94
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.31	0.28	0.20	0.23	0.00	0.25	0.31	0.40	0.00	0.45
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.30
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.06%
Enterprise Value to Invested Capital (EV/IC)	1.23	1.13	1.02	1.03	0.00	0.93	0.92	0.00	0.00	0.98
Enterprise Value to Revenue (EV/Rev)	1.57	1.65	1.54	1.59	0.00	1.55	1.62	0.00	0.00	1.86
Enterprise Value to EBITDA (EV/EBITDA)	29.90	0.00	42.83	43.61	0.00	12.24	0.00	0.00	0.00	5.64
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.73
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	17.95
Enterprise Value to Operating Cash Flow (EV/OCF)	33.67	27.94	23.34	19.96	0.00	22.84	21.95	0.00	0.00	17.83
Enterprise Value to Free Cash Flow (EV/FCFF)	5.62	112.53	51.70	0.00	0.00	15.78	16.82	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	107.40	15.70	9.33	8.18	5.76	3.84	3.22	0.00	4.33	3.14
Long-Term Debt to Equity	106.77	15.62	9.28	8.14	5.73	3.82	3.19	0.00	4.30	3.12
Financial Leverage	9.65	5.78	4.45	7.49	4.55	3.19	2.50	0.00	2.63	1.56
Leverage Ratio	19.08	11.79	9.33	14.75	9.13	6.65	5.30	0.00	5.31	4.67
Compound Leverage Factor	-830.70	16.00	-46.05	30.30	11.11	-2.25	-22.49	0.00	6.04	0.15
Debt to Total Capital	99.08%	94.01%	90.32%	89.11%	85.21%	79.34%	76.31%	0.00%	81.23%	75.83%
Short-Term Debt to Total Capital	0.58%	0.50%	0.48%	0.47%	0.45%	0.45%	0.67%	0.00%	0.45%	0.43%
Long-Term Debt to Total Capital	98.50%	93.51%	89.84%	88.64%	84.76%	78.89%	75.64%	0.00%	80.77%	75.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.01%	0.01%
Common Equity to Total Capital	0.92%	5.98%	9.67%	10.88%	14.78%	20.65%	23.68%	0.00%	18.76%	24.15%
Debt to EBITDA	25.85	-21.54	41.04	40.85	8.08	11.26	-103.63	0.00	53.56	4.57
Net Debt to EBITDA	24.05	-19.89	37.41	37.40	7.38	10.28	-93.64	0.00	49.48	4.28
Long-Term Debt to EBITDA	25.70	-21.43	40.82	40.63	8.03	11.19	-102.72	0.00	53.26	4.54
Debt to NOPAT	-18.35	-9.68	-15.12	-15.17	50.31	-142.40	-12.84	0.00	-17.01	14.55
Net Debt to NOPAT	-17.07	-8.94	-13.78	-13.88	45.98	-130.09	-11.60	0.00	-15.72	13.62
Long-Term Debt to NOPAT	-18.25	-9.62	-15.04	-15.09	50.04	-141.60	-12.73	0.00	-16.91	14.47
Altman Z-Score	0.18	0.05	0.20	0.18	0.00	0.30	0.32	0.00	0.00	0.45
Noncontrolling Interest Sharing Ratio	0.06%	0.08%	0.06%	0.10%	0.06%	0.05%	0.17%	0.00%	0.17%	0.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.66	0.56	0.60	0.61	0.65	0.65	0.78	0.00	0.69	0.65
Quick Ratio	0.33	0.29	0.24	0.27	0.27	0.30	0.37	0.00	0.38	0.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	842	305	321	-3,871	-188	288	487	4,158	453	-2,413
Operating Cash Flow to CapEx	70.39%	35.10%	102.63%	-18.86%	128.79%	32.28%	96.50%	-31.70%	19.42%	92.62%
Free Cash Flow to Firm to Interest Expense	0.00	4.13	4.33	-52.93	0.00	4.07	7.26	65.72	0.00	-45.03
Operating Cash Flow to Interest Expense	0.00	0.49	0.64	-0.11	0.00	0.77	1.19	-0.25	0.00	1.13
Operating Cash Flow Less CapEx to Interest Expense	0.00	-0.91	0.02	-0.68	0.00	-1.61	-0.04	-1.06	0.00	-0.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.39	0.37	0.37	0.37	0.37	0.37	0.35	0.00	0.35	0.40
Accounts Receivable Turnover	38.95	36.95	37.81	36.89	34.49	35.10	37.46	0.00	37.64	43.82
Inventory Turnover	66.17	68.19	67.74	71.21	76.70	70.37	68.96	0.00	78.60	74.63
Fixed Asset Turnover	2.71	2.50	2.18	2.24	2.06	2.23	2.34	0.00	2.21	2.60
Accounts Payable Turnover	14.50	7.96	13.16	18.85	15.88	8.45	13.78	0.00	12.81	25.82
Days Sales Outstanding (DSO)	9.37	9.88	9.65	9.90	10.58	10.40	9.74	0.00	9.70	8.33
Days Inventory Outstanding (DIO)	5.52	5.35	5.39	5.13	4.76	5.19	5.29	0.00	4.64	4.89
Days Payable Outstanding (DPO)	25.17	45.85	27.73	19.37	22.99	43.20	26.49	0.00	28.50	14.14
Cash Conversion Cycle (CCC)	-10.29	-30.62	-12.69	-4.35	-7.65	-27.62	-11.45	0.00	-14.16	-0.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,118	3,624	3,742	3,819	3,983	4,040	4,059	0.00	4,016	4,302
Invested Capital Turnover	0.69	0.65	0.64	1.29	0.61	0.58	0.54	0.00	0.51	0.74
Increase / (Decrease) in Invested Capital	-864	-416	-317	3,819	-33	-262	-483	-3,945	-771	2,431
Enterprise Value (EV)	3,839	4,092	3,834	3,929	0.00	3,746	3,743	0.00	0.00	4,231
Market Capitalization	751	701	485	559	0.00	598	718	911	0.00	1,021
Book Value per Share	$0.76	$5.74	$9.71	$11.21	$13.93	$19.65	$22.51	$0.00	$17.05	$21.13
Tangible Book Value per Share	($75.65)	($86.65)	($80.96)	($81.77)	($69.52)	($65.30)	($58.93)	$0.00	($61.41)	($56.88)
Total Capital	3,350	3,905	4,067	4,130	4,298	4,342	4,386	0.00	4,295	4,522
Total Debt	3,319	3,671	3,673	3,680	3,663	3,445	3,347	0.00	3,489	3,429
Total Long-Term Debt	3,299	3,651	3,654	3,661	3,643	3,425	3,318	0.00	3,469	3,409
Net Debt	3,088	3,390	3,349	3,369	3,347	3,147	3,024	0.00	3,223	3,209
Capital Expenditures (CapEx)	54	104	46	42	55	168	83	51	235	66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-442	-649	-673	-631	-598	-571	-444	0.00	-479	-443
Debt-free Net Working Capital (DFNWC)	-210	-369	-348	-320	-283	-273	-121	0.00	-214	-223
Net Working Capital (NWC)	-230	-388	-368	-340	-302	-292	-151	0.00	-233	-243
Net Nonoperating Expense (NNE)	63	137	64	122	57	88	30	34	169	18
Net Nonoperating Obligations (NNO)	3,088	3,390	3,349	3,369	3,347	3,143	3,020	0.00	3,210	3,209
Total Depreciation and Amortization (D&A)	66	81	82	163	122	80	82	77	76	77
Debt-free, Cash-free Net Working Capital to Revenue	-18.03%	-26.15%	-27.07%	-25.56%	-24.43%	-23.63%	-19.23%	0.00%	-21.23%	-19.47%
Debt-free Net Working Capital to Revenue	-8.59%	-14.85%	-14.02%	-12.97%	-11.55%	-11.30%	-5.25%	0.00%	-9.47%	-9.80%
Net Working Capital to Revenue	-9.38%	-15.63%	-14.80%	-13.76%	-12.35%	-12.10%	-6.53%	0.00%	-10.33%	-10.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.76)	($5.10)	($1.24)	($3.61)	($5.16)	($1.15)	($0.48)	$0.00	($8.34)	$0.01
Adjusted Weighted Average Basic Shares Outstanding	48.47M	48.60M	48.50M	48.12M	53.35M	53.58M	53.94M	0.00	58.11M	57.02M
Adjusted Diluted Earnings per Share	($1.76)	($5.10)	($1.24)	($3.61)	($5.12)	($1.15)	($0.48)	$0.00	($8.34)	$0.01
Adjusted Weighted Average Diluted Shares Outstanding	48.47M	48.60M	48.50M	48.12M	53.35M	53.58M	53.94M	0.00	58.11M	57.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.51M	40.67M	40.63M	40.48M	40.09M	45.62M	45.63M	0.00	46.68M	47.26M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-110	3.90	-52	-221	26	4.19	213	-318	38
Normalized NOPAT Margin	-3.89%	-17.52%	0.63%	-8.37%	-36.16%	4.12%	0.69%	35.50%	-55.17%	6.50%
Pre Tax Income Margin	-11.51%	-44.68%	-9.92%	-23.05%	-70.24%	-2.82%	-8.96%	52.79%	-89.73%	0.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-2.81	0.17	-0.95	0.00	0.75	0.19	6.00	0.00	1.03
NOPAT to Interest Expense	0.00	-1.49	0.05	-0.71	0.00	0.37	0.06	3.36	0.00	0.34
EBIT Less CapEx to Interest Expense	0.00	-4.21	-0.46	-1.52	0.00	-1.64	-1.05	5.19	0.00	-0.19
NOPAT Less CapEx to Interest Expense	0.00	-2.90	-0.57	-1.28	0.00	-2.01	-1.18	2.56	0.00	-0.88
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-9.03%	-11.95%	-14.70%	-52.84%	-12.93%	-33.39%	-37.56%	-36.04%	178.30%

Frequently Asked Questions About Bally's' Financials

When does Bally's's financial year end?

According to the most recent income statement we have on file, Bally's' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Bally's' net income changed over the last 2 years?

Bally's' net income appears to be on an upward trend, with a most recent value of -$567.75 million in 2024, rising from -$425.55 million in 2022. The previous period was -$187.50 million in 2023. Check out Bally's' forecast to explore projected trends and price targets.

What is Bally's's operating income?

Bally's's total operating income in 2024 was -$258.33 million, based on the following breakdown:

Total Gross Profit: $1.33 billion
Total Operating Expenses: $1.59 billion

How has Bally's revenue changed over the last 2 years?

Over the last 2 years, Bally's' total revenue changed from $2.26 billion in 2022 to $2.45 billion in 2024, a change of 8.6%.

How much debt does Bally's have?

Bally's' total liabilities were at $5.83 billion at the end of 2024, a 6.4% decrease from 2023, and a 6.1% increase since 2022.

How much cash does Bally's have?

In the past 2 years, Bally's' cash and equivalents has ranged from $163.19 million in 2023 to $212.52 million in 2022, and is currently $171.23 million as of their latest financial filing in 2024.

How has Bally's' book value per share changed over the last 2 years?

Over the last 2 years, Bally's' book value per share changed from 17.05 in 2022 to 0.76 in 2024, a change of -95.5%.

Related Companies

This page (NYSE:BALY) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bally's (BALY) Financials

Frequently Asked Questions About Bally's' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bally's (BALY) Financials

Annual Income Statements for Bally's

Quarterly Income Statements for Bally's

Annual Cash Flow Statements for Bally's

Quarterly Cash Flow Statements for Bally's

Annual Balance Sheets for Bally's

Quarterly Balance Sheets for Bally's

Annual Metrics And Ratios for Bally's

Quarterly Metrics And Ratios for Bally's

Frequently Asked Questions About Bally's' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools